248 related articles for article (PubMed ID: 30257595)
1. A mitochondrial based oncology platform for targeting cancer stem cells (CSCs): MITO-ONC-RX.
Sotgia F; Ozsvari B; Fiorillo M; De Francesco EM; Bonuccelli G; Lisanti MP
Cell Cycle; 2018; 17(17):2091-2100. PubMed ID: 30257595
[TBL] [Abstract][Full Text] [Related]
2. First-in-class candidate therapeutics that target mitochondria and effectively prevent cancer cell metastasis: mitoriboscins and TPP compounds.
Ózsvári B; Sotgia F; Lisanti MP
Aging (Albany NY); 2020 May; 12(11):10162-10179. PubMed ID: 32452826
[TBL] [Abstract][Full Text] [Related]
3. Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: treating cancer like an infectious disease.
Lamb R; Ozsvari B; Lisanti CL; Tanowitz HB; Howell A; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Oncotarget; 2015 Mar; 6(7):4569-84. PubMed ID: 25625193
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells.
De Luca A; Fiorillo M; Peiris-Pagès M; Ozsvari B; Smith DL; Sanchez-Alvarez R; Martinez-Outschoorn UE; Cappello AR; Pezzi V; Lisanti MP; Sotgia F
Oncotarget; 2015 Jun; 6(17):14777-95. PubMed ID: 26087310
[TBL] [Abstract][Full Text] [Related]
5. Targeting flavin-containing enzymes eliminates cancer stem cells (CSCs), by inhibiting mitochondrial respiration: Vitamin B2 (Riboflavin) in cancer therapy.
Ozsvari B; Bonuccelli G; Sanchez-Alvarez R; Foster R; Sotgia F; Lisanti MP
Aging (Albany NY); 2017 Dec; 9(12):2610-2628. PubMed ID: 29253841
[TBL] [Abstract][Full Text] [Related]
6. A new mutation-independent approach to cancer therapy: Inhibiting oncogenic RAS and MYC, by targeting mitochondrial biogenesis.
Ozsvari B; Sotgia F; Lisanti MP
Aging (Albany NY); 2017 Oct; 9(10):2098-2116. PubMed ID: 29080556
[TBL] [Abstract][Full Text] [Related]
7. Doxycycline, Azithromycin and Vitamin C (DAV): A potent combination therapy for targeting mitochondria and eradicating cancer stem cells (CSCs).
Fiorillo M; Tóth F; Sotgia F; Lisanti MP
Aging (Albany NY); 2019 Apr; 11(8):2202-2216. PubMed ID: 31002656
[TBL] [Abstract][Full Text] [Related]
8. High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant.
Farnie G; Sotgia F; Lisanti MP
Oncotarget; 2015 Oct; 6(31):30472-86. PubMed ID: 26421710
[TBL] [Abstract][Full Text] [Related]
9. Targeting cancer stem cell propagation with palbociclib, a CDK4/6 inhibitor: Telomerase drives tumor cell heterogeneity.
Bonuccelli G; Peiris-Pages M; Ozsvari B; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Oncotarget; 2017 Feb; 8(6):9868-9884. PubMed ID: 28039467
[TBL] [Abstract][Full Text] [Related]
10. Cancer stem cell fate determination: mito-nuclear communication.
Fan M; Shi Y; Zhao J; Li L
Cell Commun Signal; 2023 Jun; 21(1):159. PubMed ID: 37370081
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition.
Lamb R; Harrison H; Hulit J; Smith DL; Lisanti MP; Sotgia F
Oncotarget; 2014 Nov; 5(22):11029-37. PubMed ID: 25415228
[TBL] [Abstract][Full Text] [Related]
12. Targeting hypoxic cancer stem cells (CSCs) with Doxycycline: Implications for optimizing anti-angiogenic therapy.
De Francesco EM; Maggiolini M; Tanowitz HB; Sotgia F; Lisanti MP
Oncotarget; 2017 Aug; 8(34):56126-56142. PubMed ID: 28915578
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial markers predict recurrence, metastasis and tamoxifen-resistance in breast cancer patients: Early detection of treatment failure with companion diagnostics.
Sotgia F; Fiorillo M; Lisanti MP
Oncotarget; 2017 Sep; 8(40):68730-68745. PubMed ID: 28978152
[TBL] [Abstract][Full Text] [Related]
14. Exploiting mitochondrial targeting signal(s), TPP and bis-TPP, for eradicating cancer stem cells (CSCs).
Ozsvari B; Sotgia F; Lisanti MP
Aging (Albany NY); 2018 Feb; 10(2):229-240. PubMed ID: 29466249
[TBL] [Abstract][Full Text] [Related]
15. Doxycycline, an Inhibitor of Mitochondrial Biogenesis, Effectively Reduces Cancer Stem Cells (CSCs) in Early Breast Cancer Patients: A Clinical Pilot Study.
Scatena C; Roncella M; Di Paolo A; Aretini P; Menicagli M; Fanelli G; Marini C; Mazzanti CM; Ghilli M; Sotgia F; Lisanti MP; Naccarato AG
Front Oncol; 2018; 8():452. PubMed ID: 30364293
[No Abstract] [Full Text] [Related]
16. Bergamot natural products eradicate cancer stem cells (CSCs) by targeting mevalonate, Rho-GDI-signalling and mitochondrial metabolism.
Fiorillo M; Peiris-Pagès M; Sanchez-Alvarez R; Bartella L; Di Donna L; Dolce V; Sindona G; Sotgia F; Cappello AR; Lisanti MP
Biochim Biophys Acta Bioenerg; 2018 Sep; 1859(9):984-996. PubMed ID: 29626418
[TBL] [Abstract][Full Text] [Related]
17. Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs).
Fiorillo M; Lamb R; Tanowitz HB; Cappello AR; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Aging (Albany NY); 2016 Aug; 8(8):1593-607. PubMed ID: 27344270
[TBL] [Abstract][Full Text] [Related]
18. OXPHOS-targeting drugs in oncology: new perspectives.
Kalyanaraman B; Cheng G; Hardy M; You M
Expert Opin Ther Targets; 2023; 27(10):939-952. PubMed ID: 37736880
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial transplantation regulates antitumour activity, chemoresistance and mitochondrial dynamics in breast cancer.
Chang JC; Chang HS; Wu YC; Cheng WL; Lin TT; Chang HJ; Kuo SJ; Chen ST; Liu CS
J Exp Clin Cancer Res; 2019 Jan; 38(1):30. PubMed ID: 30674338
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signaling.
Lamb R; Bonuccelli G; Ozsvári B; Peiris-Pagès M; Fiorillo M; Smith DL; Bevilacqua G; Mazzanti CM; McDonnell LA; Naccarato AG; Chiu M; Wynne L; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Oncotarget; 2015 Oct; 6(31):30453-71. PubMed ID: 26421711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
